Sign in
4

Changes in Ownership

Neurogene Inc. Filed Acc 0001209191-23-006881

Chief Medical Officer sold 14,380 shares at $0.60 ($8,588)

  • Chief Medical Officer acquired 35,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Patel Priti · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-01 Exercise or conversion : show line 1 in the form +35,000 45,462 D
2023-02-02 Sale : show line 2 in the form −14,380 $0.60 $8,588 31,082 D
Open-market sales · 14,380 sh · avg $0.60 · $8,588

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-01 Exercise or conversion : show line 3 in the form Restricted Stock Units −35,000 35,000 D
Loading xslF345X03/doc4.xml…